Name | AMP-Deoxynojirimycin |
---|---|
Synonyms |
(2R,3R,4R,5S)-1-{5-[(3s,5s,7s)-Adamantan-1-ylmethoxy]pentyl}-2-(hydroxymethyl)-3,4,5-piperidinetriol
(2R,3R,4R,5S)-1-[5-(Adamantan-1-ylmethoxy)pentyl]-2-(hydroxymethyl)-3,4,5-piperidinetriol 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-1-[5-(tricyclo[3.3.1.1]dec-1-ylmethoxy)pentyl]-, (2R,3R,4R,5S)- |
Description | AMP-Deoxynojirimycin (AMP-DNM) is a potent ceramide glucosyltransferase and GCase 2 inhibitor. AMP-Deoxynojirimycin also is a GlcCer biosynthesis inhibitor[1][2]. |
---|---|
Related Catalog | |
In Vitro | AMP-Deoxynojirimycin (10 μM) significantly blocks the leucine and C17ISO-induced P70S6K phosphorylation in 3T3-L1 cells[1]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 569.9±50.0 °C at 760 mmHg |
Molecular Formula | C22H39NO5 |
Molecular Weight | 397.549 |
Flash Point | 298.4±30.1 °C |
Exact Mass | 397.282837 |
PSA | 93.39000 |
LogP | 3.04 |
Vapour Pressure | 0.0±3.6 mmHg at 25°C |
Index of Refraction | 1.570 |